E Jantunen Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

1/2019	Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients.
11/2017	Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly.
6/2012	Pre-emptive plerixafor injection increases blood neutrophil, lymphocyte and monocyte counts in addition to CD34+ counts in patients with non-Hodgkin lymphoma mobilizing poorly with chemotherapy plus G-CSF: potential implications for apheresis and graft composition.
8/2006	Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
2/2006	Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis.
12/2005	Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
9/2005	Outcome of progressive disease after autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a nation-wide survey.
9/2003	Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?
7/2003	BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy.
6/2002	Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E Jantunen Research Topics

Disease

12	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 10/2000
7	Lymphoma (Lymphomas) 01/2020 - 05/2000
4	Multiple Myeloma 03/2016 - 03/2003
4	Cardiotoxicity 12/2005 - 01/2001
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 07/2008
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2010 - 05/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2008 - 02/2003
2	Neoplasms (Cancer) 12/2006 - 01/2001
2	Heart Failure 06/2002 - 01/2001
2	Left Ventricular Dysfunction 03/2002 - 12/2001
2	Autoimmune Diseases (Autoimmune Disease) 02/2000 - 01/2000
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2012
1	Neutropenia 10/2010
1	Infections 10/2010
1	Sepsis (Septicemia) 01/2009
1	Plasmacytoma 05/2005
1	Immunoglobulin Light-chain Amyloidosis 12/2004
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2004
1	Enteropathy-Associated T-Cell Lymphoma 12/2003
1	Fever (Fevers) 03/2003
1	Aspergillosis 12/2002
1	Cardiomyopathies (Cardiomyopathy) 01/2001
1	Ankylosing Spondylitis 05/2000
1	Mixed Connective Tissue Disease (MCTD) 01/2000
1	Polymyositis 01/2000

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2002 - 04/2001
3	pegfilgrastim (Neulasta)FDA Link 01/2019 - 11/2017
3	plerixafor FDA Link 12/2017 - 06/2012
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2016 - 03/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2006 - 01/2000
3	AnthracyclinesIBA 12/2005 - 01/2001
3	Radioisotopes (Radionuclides)IBA 12/2001 - 01/2001
2	Filgrastim (Neupogen)FDA Link 01/2019 - 11/2017
2	Natriuretic PeptidesIBA 03/2002 - 12/2001
1	CytokinesIBA 01/2019
1	Lenalidomide (CC 5013)FDA Link 03/2016
1	C-Reactive ProteinIBA 01/2009
1	posaconazole FDA Link 06/2008
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2003
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2003
1	Methylprednisolone FDA LinkGeneric 02/2003
1	Antifungal AgentsIBA 12/2002
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2001
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2001
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2001
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2001
1	imciromab pentetate FDA Link 01/2001

Therapy/Procedure

18	Stem Cell Transplantation 01/2020 - 01/2000
14	Therapeutics 01/2020 - 01/2000
11	Drug Therapy (Chemotherapy) 01/2019 - 10/2000
3	Blood Component Removal (Apheresis) 12/2017 - 03/2003
2	Transplantation 01/2020 - 01/2012
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 10/2000 - 01/2000
1	Hematopoietic Stem Cell Transplantation 01/2020
1	Hematopoietic Stem Cell Mobilization 03/2016
1	Platelet Transfusion (Blood Platelet Transfusions) 03/2003
1	Homologous Transplantation 12/2002